DocGo Inc. (NASDAQ:DCGO) Short Interest Update

DocGo Inc. (NASDAQ:DCGO) saw a large growth in short interest in April. As of April 15th, there was short interest totaling 6,400,268 shares, a growth of 16.5% from the March 31st total of 5,492,962 shares. Based on an average daily trading volume, of 1,482,587 shares, the days-to-cover ratio is currently 4.3 days. Currently, 6.7% of the shares of the stock are short sold.

DocGo Trading Down 4.4%

Shares of NASDAQ DCGO traded down $0.03 during midday trading on Friday, reaching $0.67. The company’s stock had a trading volume of 655,858 shares, compared to its average volume of 1,047,427. The company has a 50 day moving average price of $0.65 and a 200 day moving average price of $0.85. DocGo has a one year low of $0.49 and a one year high of $2.45. The company has a market cap of $66.60 million, a price-to-earnings ratio of -0.36 and a beta of 1.02.

Wall Street Analysts Forecast Growth

DCGO has been the topic of a number of recent analyst reports. Stifel Nicolaus dropped their price target on shares of DocGo from $4.00 to $2.50 and set a “buy” rating on the stock in a research report on Tuesday, March 17th. Canaccord Genuity Group dropped their price target on shares of DocGo from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday, March 25th. Cantor Fitzgerald restated an “overweight” rating and set a $3.00 price target on shares of DocGo in a research report on Tuesday, March 17th. Finally, Needham & Company LLC restated a “buy” rating and set a $3.00 price target on shares of DocGo in a research report on Tuesday, March 17th. Three equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $2.38.

Institutional Trading of DocGo

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Isthmus Partners LLC raised its holdings in shares of DocGo by 14.0% in the 1st quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock worth $637,000 after purchasing an additional 124,211 shares in the last quarter. Empowered Funds LLC raised its holdings in shares of DocGo by 14.6% in the 4th quarter. Empowered Funds LLC now owns 138,306 shares of the company’s stock worth $121,000 after purchasing an additional 17,607 shares in the last quarter. Boothbay Fund Management LLC raised its holdings in shares of DocGo by 39.0% in the 4th quarter. Boothbay Fund Management LLC now owns 200,947 shares of the company’s stock worth $176,000 after purchasing an additional 56,413 shares in the last quarter. Bridgeway Capital Management LLC raised its holdings in shares of DocGo by 45.5% in the 4th quarter. Bridgeway Capital Management LLC now owns 539,306 shares of the company’s stock worth $473,000 after purchasing an additional 168,607 shares in the last quarter. Finally, Jain Global LLC bought a new stake in shares of DocGo in the 4th quarter worth approximately $70,000. 56.44% of the stock is currently owned by institutional investors.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.